Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.77% | -12.81% | -1,775.05% | -6.04% | 17.96% |
| Total Depreciation and Amortization | -26.71% | -63.47% | 46.16% | 28.79% | 21.74% |
| Total Amortization of Deferred Charges | 228.38% | 254.05% | -0.56% | 1.35% | 0.00% |
| Total Other Non-Cash Items | -22.34% | -5.79% | 5.52% | 23.66% | 12.21% |
| Change in Net Operating Assets | -25.10% | 91.21% | 22.94% | 22.20% | 137.46% |
| Cash from Operations | -54.03% | 72.46% | -90.78% | 23.22% | 78.05% |
| Capital Expenditure | 53.83% | 13.58% | 21.99% | 1.89% | -175.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 513.84% | -388.30% | 85.74% | 33.84% | -93.75% |
| Cash from Investing | 317.01% | -312.67% | 182.55% | 51.59% | -114.52% |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | -174.49% | -- | -- | -- | -- |
| Issuance of Common Stock | -93.10% | -23.53% | 22.81% | 2,912.50% | -62.70% |
| Repurchase of Common Stock | -85.71% | 48.38% | -141.94% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -29.48% | -108.51% | 5,215.38% | -225.00% | 217.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.63% | -157.57% | 497.63% | 93.97% | -160.13% |